Trial Profile
Clinical Trials Insight: 700027555
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2007
Price :
$35
*
At a glance
- Drugs INCB 8696 (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Sponsors Incyte Corporation
- 08 Nov 2007 Status changed from planning to recruiting.
- 10 Oct 2007 New trial record.